Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1986
Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin)
S E Monroe, Z Blumenfeld, J L Andreyko, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1981
Naproxen sodium, aspirin, and placebo in primary dysmenorrhea. Reduction of pain and blood levels of prostaglandin F2-alpha metabolite
Z Rosenwaks, G S Jones, M R Henzl, et al.
Obstetrics and Gynecology
|
October 1, 1984
Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis
W Droegemueller, D G Adamson, D Brown, et al.
Fertility and Sterility
|
March 1, 1985
Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycle
S E Monroe, M R Henzl, M C Martin, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1988
Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone
R L Chan, M R Henzl, M E LePage, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
January 1, 1996
Gonadotropin-releasing hormone agonist analog (nafarelin): a useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism
G B Kletter, A Rolfes-Curl, J C Goodpasture, et al.
The Journal of Reproductive Medicine
|
November 1, 1986
Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo
D Brown, M R Henzl, M E LePage, et al.
The Journal of Reproductive Medicine
|
July 1, 1989
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis
R H Kaufman, M R Henzl, D Brown, et al.
American Journal of Obstetrics and Gynecology
|
January 10, 1998
Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel)
G D Adamson, W L Heinrichs, M R Henzl, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1986
Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin)
S E Monroe, Z Blumenfeld, J L Andreyko, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1981
Naproxen sodium, aspirin, and placebo in primary dysmenorrhea. Reduction of pain and blood levels of prostaglandin F2-alpha metabolite
Z Rosenwaks, G S Jones, M R Henzl, et al.
Obstetrics and Gynecology
|
October 1, 1984
Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis
W Droegemueller, D G Adamson, D Brown, et al.
Fertility and Sterility
|
March 1, 1985
Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycle
S E Monroe, M R Henzl, M C Martin, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1988
Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone
R L Chan, M R Henzl, M E LePage, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
January 1, 1996
Gonadotropin-releasing hormone agonist analog (nafarelin): a useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism
G B Kletter, A Rolfes-Curl, J C Goodpasture, et al.
The Journal of Reproductive Medicine
|
November 1, 1986
Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo
D Brown, M R Henzl, M E LePage, et al.
The Journal of Reproductive Medicine
|
July 1, 1989
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis
R H Kaufman, M R Henzl, D Brown, et al.
American Journal of Obstetrics and Gynecology
|
January 10, 1998
Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel)
G D Adamson, W L Heinrichs, M R Henzl, et al.
Page
of 3